Researchers at uOttawa institute hope network closes gender gap in heart health prevention and care

  • 📰 OttawaCitizen
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Cardiovascular disease is the leading cause of death in women over 35 around the world.

Researchers at the University of Ottawa Heart Institute are hoping the creation of a network to improve cardiovascular disease prevention and care in women will close some of those gaps.Sign up to receive daily headline news from Ottawa Citizen, a division of Postmedia Network Inc.By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails or any newsletter.

Mullen said the network will target women who are at higher risk of cardiovascular disease. That includes women who had blood pressure-related pregnancy complications and higher risk populations, including Indigenous women and South Asian women. Mullen said one of the aims of the network will be to make sure the symptoms that are more common in women are recognized.

“There is still work to be done,” she said. “The reality is that heart disease for so long has been called a man’s disease.”Article content

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 21. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Paxlovid should only be prescribed to those with COVID that are high risk of severe outcomes: studyA new Ontario study underscores the benefits of Paxlovid. Researchers say it also suggest that restricting the drug to those who are at the highest risk of severe outcomes from COVID may be the most cost-effective method. Yeah sure ! Don’t take this stuff as it’s full chemicals. Seek natural medicines not some pharma scam So Pfizer came out with a dressed up version of Ivermectin Now cost matters? What about when we were paying people to sit at home? We should do what saves the most lives because I’m sure this study doesn’t account for lost productivity due to someone getting sick and the emotional toll on one’s family
Source: TorontoStar - 🏆 60. / 55 Read more »